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Abstract: The gastrointestinal tract (GIT) of vertebrates is composed of several distinct 
  compartments and glands as well as an extensive mucosal surface. Its primary function is that 
of chemical and physical digestion of food and the absorption of nutrients; however, due to its 
continual antigen exposure, the GIT also has an important defensive immunological function. 
The GIT’s immunological participation is facilitated by the mucosa-associated lymphoid tissues, 
thought to share the mucosal immunological system with the respiratory mucosa-associated 
lymphoid tissues. As a result of this shared mucosal immunity, it has been hypothesized that 
bronchial asthma may be able to affect the body’s GIT in the same pathophysiological manner as 
the airways and lungs. Here we discuss the link between bronchial asthma and   pathophysiological 
features in the GIT – including leukocyte influx, goblet cell alterations, fibrosis, and epithelial 
and villous atrophy.
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Within the vertebrate body the gastrointestinal tract (GIT) plays numerous vital roles, 
including the digestion of food, the absorption of nutrients and water, and the formation 
of feces for elimination.1,2 Another essential role of the intestines is immune defense 
due to continual exposure to various antigens, both harmless and pathogenic, from the 
vertebrate’s consumed food and resident, commensal organisms. Its immunological par-
ticipation is facilitated by the GIT’s mucosa-associated lymphoid tissues.3–5 This tissue is 
thought to be connected to the respiratory system, as will be explained below, by means 
of the mucosal immunological system. The examination of the GIT amongst asthmatics 
has shown various pathological alterations, some of which correlate to that seen in the 
respiratory system, under similar conditions, and may have arisen due to bronchial asthma 
using the mucosal immunological system as a means of affecting this region of the body. 
In this review we will assess the connection that may allow for this process to arise, as 
well as the documented alterations identified within the GIT of asthmatics.
This review was construed based upon articles and reviews found through Medline, 
PubMed, Science Direct, and Scopus using various search terms including asthma, 
GIT, GALT, stomach, intestines, and pathophysiological effects.
The common mucosal system
The gut associated lymphoid tissue (GALT) is the specialized barrier with which the 
mucosal immune system is associated within the GIT.2,4 The lymphoid tissue of this 
organ is present in the GIT as diffuse lymphocytic infiltrate or large   nonencapsulated 
aggregations, such as Peyer’s patches.2 It is exposed   continually to antigens, which it Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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must determine the nature of – either harmless (such as food 
and commensal organisms) or dangerous (pathogens) – so as 
to protect the body from the external environment.4,5
The mucosa-associated lymphoid tissues are resident not 
only in the GIT but also within the respiratory tissues. Both 
the respiratory tissues and GIT-associated mucosal surfaces 
have numerous common morphological and functional char-
acteristics, with the mucosal immunological system believed 
to be one such common feature.3
The mucosal immune system comprises of three lines 
of defense:
1.  The non-specific first line defense system – that is the 
epithelium cells which essentially act as a sieve with 
the aim of preventing foreign, unwanted antigens from 
penetrating the mucosa.4
2.  The innate defense system – that being composed of 
natural killer cells, macrophages, and epithelial cells.4
3.  The adaptive immune defense system – composed of the 
lamina propria, lymphocytes, and Peyer’s patches.4
Animal experiments have proven that selective trafficking 
of lymphocytes occurs between these two mucosal surfaces, 
with migration being facilitated through the lymphatic and 
circulatory systems that connect the body’s various glan-
dular and mucosal sites.5 Although this process has been 
demonstrated within numerous animal studies, little data 
exist to support its occurrence in humans. Human B and 
T lymphocytes, macrophages, and mast cells do appear to 
  communicate between lymphoid populations of mucosal 
  tissues; for example, activated lymphocytes have been shown 
to circulate between the mucosal tissues of the lungs, salivary 
glands, and GIT in human asthmatics.3,5,6
It is subsequently hypothesized that this connection in 
mucosal immunity of the body causes bronchial asthma to 
affect the entire body’s mucosal system, in turn giving rise 
to the same pathophysiological features associated with 
asthma in the respiratory tissues in the GIT.5,6 Hypoxemia, 
hypercapnia development, microcirculatory alterations, 
and endocrine impairment within the GIT are some of the 
pathophysiological features that have been reported amongst 
suffers of the disease, helping to validate this hypothesis.7 
Scientific literature, in terms of this topic, constitutes only 
a few studies but appears to support the hypothesis that a 
link exists between bronchial asthma and the GIT. Further 
research on this topic would greatly help to validate and to 
understand the already existing, although limited, knowledge 
available.
The two compartments of the GIT which have been exam-
ined within the literature under asthmatic conditions, are the 
stomach, which holds acidic gastric contents and facilitates a 
churning action to reduce the ingested bolus to acidic chyme, 
and the small intestine, the essential absorption and digestive 
unit of the GIT. The large intestine, participating in water 
absorption, final digestion, and the formation of feces, does 
not appear to have been assessed under asthmatic conditions 
within literature.1,2 Table 1 summarizes the   overlapping 
  pathological features described in scientific literature 
Table 1 The overlapping pathological features, ascribed to asthma, within different regions of the body, namely the lungs and airways, 
the small intestine, and the stomach, of humans
Phenomena ascribed  
to asthma
Lungs and airways Small intestine Stomach
Cellular atrophy  
Surface epithelium
 
Surface, pit, crypt, and  
glandular epithelium
 
Surface, pit, crypt, and   
glandular epithelium
Fibrosis   ?
increased cellular factor  
presence
 
Numerous pro-inflammatory  
factors including iL5/13
 
iL-5/13 and CMCSF
?
increased leukocyte  
infiltration
 
eosinophils, lymphocytes, mast  
cells, monocytes/macrophages,  
and neutrophils
 
eosinophils, lymphocytes,  
and mast cells
 
Lymphocytes
Mucus composition  
alterations
 
Goblet cells
?  
Fundic surface  
epithelium
Thought to be a T-cell  
mediated disease
  ?
Note:  = present, ? = unknown.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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between the body’s lungs and airways, stomach, and small 
intestines, which will be discussed in detail below.
The effects of asthma 
on the stomach
The stomach of asthmatics has been observed as undergoing 
various structural and histological alterations.
Cellular atrophy
When undiluted, the stomachs mucosa and submucosa are 
present in a state of prominent longitudinal folds – rugae. 
These folds allow the stomach the ability to distend and 
smooth out upon food acquisition, although the stomach’s 
surface still retains an irregular appearance due to the 
surfaces subdivision by grooves – gastric areas.1,2,8,9 These 
gastric areas possess pits or floveolae, in to which three to 
seven gastric glands open.8 The cardia, situated at the 
entrance of the stomach from the esophagus, and pylorus, 
the terminal funnel-shaped region of the stomach, have 
similar histology in term of their gastric glands. Both are 
rich in simple or branched tubular mucosa mucus-secreting 
glands, which open into the floveolae.2,8,10 The mucosa of 
the fundus and corpus possess straight, tubular gastric 
glands, although they may also possess basal branching 
glands.2,9
Simple columnar epithelial cells, each with basal oval nuclei 
and mucin droplets, cover the luminal surface of the stomach.9 
They participate in protecting the stomach from self-digestion 
from the stomach’s own proteolytic and acidic secretions.2,8
A light microscopic study has revealed that the stomach 
undergoes degeneration processes as well as surface, pit, 
crypt, and glandular epithelium atrophy.7 Erosive lesions 
have been reported in the stomach’s mucosa, found in con-
junction with parietal cell hyperplasia and hyperfunctioning; 
parietal cells being responsible for the stomachs hydrochlo-
ric acid production and secretion.2,7–9 It is believed that the 
lesions arise as a result of a gastrin-induced event whereby 
the stomach’s parietal cells are overstimulated though an 
overproduction of histamine by ECL and mast cells.7
Hemodynamic alterations
The lamina propria and submucosa of the stomach are rich in 
blood vessels which provide the necessary metabolites as well 
as waste-product, absorbed nutrient, and metabolite removal 
services. They also provide the stomach with the necessary 
regulating factors, for the regulation of the mucosal glands 
secretary activities.1,2,8,9
The bronchial blood vessels of asthmatics undergo numer-
ous alterations, including angiogenesis, hypertrophy, and 
vasodilation.11–13 Numerous vasoactive biomolecules have 
been identified as possible candidates for these   hemodynamic 
alterations within the respiratory tissues of   asthmatics, includ-
ing histamine, interleukin-8 (IL-8), and, of particular impor-
tance in facilitating angiogenesis,   vascular   endothelial growth 
factor (VEGF).11,14,15   Hemodynamic alterations, primarily 
within in the gastric folds where the   endothelium reveals a 
heterogeneous structure, have been reported amongst asth-
matics.7 Further research is required to   determine whether 
or not these stomach hemodynamic   alterations are facilitated 
by the same vasoactive   biomolecules as in the respiratory 
systems of asthmatics.
Leukocyte influx
Due to the stomach’s continual exposure to antigens, it plays 
an essential role in the body’s immune defense. The GALT 
of the stomach, like that of the rest of the GIT, is essential 
in preventing harmful antigen uptake while still allowing 
the absorption of nutrient molecules.16 The GALT of the 
stomach is composed of numerous parts including diffuse 
lymphatic tissues, intraepithelial lymphocytes, epithelium, 
and eosinophils. Lymphatic nodules have been identified 
in human and animal tonsils, ileum, and appendix but their 
presence in the stomach has not been studied in-depth.17 The 
cardiac glandular region of the Bactrian camel’s stomach has 
been reported to hold lymphatic nodules, while   Eroschenko 
(2005) has documented the occasional presence of human 
fundic and pyloric lamina propria sub-glandular lymphoid 
nodules.17 All the lymphoid elements, responsible for 
controlling immune responses, are composed of T and B 
lymphocytes. Eosinophils, due their prominent recruitment 
to the body’s GIT under control conditions, are a common 
infiltrating leukocyte of the stomach.18,19
A defining histopathological feature of the respiratory 
tissues amongst asthmatics is the increased infiltration 
of leukocytes, predominantly eosinophils and allergen-
specific clusters of differentiation (CD) 4+ T helper (Th) 
2 cells.4,13,14,20–24 The entire stomach’s mucosa, as in the 
respiratory tissues, during asthma has been noted to show 
an increased influx of lymphocytes; however, no researchers 
to date have determined if these invading lymphocytes are 
allergen-specific CD4+ Th2 cells.7 As enhanced leukocyte 
infiltration into a vascularized tissue is a common feature of 
inflammation, the stomach of asthmatics may be in a state 
of inflammation.20,25Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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Mucus production alterations
Goblet cell hyperplasia and increased mucus production 
is commonly described within the airways of   asthmatics 
along with an alteration in the composition of the released 
mucus.12,26,27 Under asthmatic conditions, mucin protein 
expression appears to be altered, with the mucus itself being 
found to be more adhesive and less fluid in nature.12–14,27,28
The fundal surface epithelium mucin granules have 
been seen to possess a polymorphic nature based upon 
the severity of the individual’s asthma. Severe to moder-
ate asthmatics possess mucin granules with an electron 
transparent nature when viewed under a TEM while mild 
to moderate asthmatics’ mucin granules possess a osmo-
philic nature.7 Moderate to severe asthmatics hold a large 
number of mixt-cells, in possession of a large number of 
mucin granules, within their fundal glands. The occurrence 
of these mixt-cells may either be the result of delayed glan-
dular differentiation or the inhibition of protein synthesis 
due to stomach degeneration and emergency compensation 
through increased mucus production.7 In the pylorus, on 
the other hand, surface epithelium cells possess round, 
electron dense granules and, within moderate asthmatics, 
hyperplasia of its endocrine cells.7
The effects of asthma on the small 
intestine
The entire small intestinal mucosa of asthmatic humans 
has been shown to undergo architectural abnormalities and 
cytokine production alterations similar to those in the bron-
chial mucosa during asthma as well as being reminiscent of 
the pathology associated with gluten-sensitive enteropathy 
(GSE).5
Blood vessel alterations
The lamina propria and submucosa of the small intestine, as 
in the stomach, are rich in blood vessels which provide the 
necessary metabolites as well as waste products and absorbed 
nutrients, such as amino acids and monosaccharides derived 
from protein and carbohydrate catabolism, respectively, at 
this absorption site, removal services.1,2,8,9,29 They also supply 
agents which help to regulate the small intestine’s digestive 
functions.1,2,8,9
Bronchial blood vessels of asthmatics undergo numer-
ous alterations, including angiogenesis, hypertrophy, and 
vasodilation.11–13 Numerous vasoactive biomolecules have 
been identified as possible candidates for these   hemodynamic 
alterations within the respiratory tissues of asthmatics, 
including histamine, IL-8, and, of particular importance, 
VEGF.11,14,15 The villi’s microcirculatory beds present an 
endothelium of a heterogeneous nature under asthmatic 
  conditions.7 Further research is required to determine whether 
or not these intestinal hemodynamic alterations are facilitated 
by the same vasoactive biomolecules as in the respiratory 
systems of asthmatics.
Cytokine alterations
IL-5 and IL-13 are found at increased levels within the 
mucosa of asthmatic airways compared to those of nonas-
thmatics.30,31 An increase in the mucosa’s IL-13, IL-5, and 
cellular macrophage colony stimulating factor (CMCSF) 
content has also been identified in the GIT’s lamina proprias 
eosinophil granules and mast cells cytoplasmic granules.5 
Whether these eosinophils and mast cells are derived from 
the asthmatic respiratory system, via the common mucosal 
immune system, or arise in the small intestine itself, 
due to the surrounding possibly inflammatory stimuli, is 
unknown. Interestingly, the lymphocytes of the GIT are 
unable to express these cytokines, although the bronchi 
can. It is speculated that this difference between the GIT 
and bronchi lymphocytes may be due to exposure to dif-
ferent cytokine microenvironments at these two distinct 
mucosal sites, resulting in different cytokine expression by 
the lymphocytes.5 The role of IL-13, IL-5, and CMCSF in 
the intestine during asthma is unknown; however, they are 
involved in eosinophil survival, proliferation, and function 
as well as in modulating the body’s immune responses at 
mucosal sites.5
Fibrosis in the lungs and GiT
Fibrosis can be defined as an incorrectly regulated wound 
healing process, commonly facilitated by chronic inflam-
mation as a result of repeated injury and repair processes 
occurring.32 Myofibroblasts are the most important cellular 
participants in this, traditionally considered, CD4+ Th2 cell 
cytokine system. The importance of these fibroblastic cells, 
located within the body’s granulation tissues, is related to 
that fact that they are able to produce and control a majority 
of the factors and functions specific to the disease.32
Fibrosis via the accumulation of sub-epithelial myofibro-
blasts is a prominent feature of asthmatic airway remodeling.12,14 
This process can affect the structure of the airways through the 
  secretions of various growth   factors, inflammatory   molecules 
and ECM elements by the   myofibroblasts themselves.12 Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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  Moderate diffuse fibrosis may be present within the small 
intestine of asthmatics.7 Its presence is understandable in the 
GIT as fibrosis commonly occurs in response to inflammation, 
which would appear to be present in the GIT of asthmatics 
due the feature of increased leukocyte influx, and may even 
contribute to furthering this inflammatory state.32,33
Leukocyte infiltration
The body’s small intestine is exposed to an array of bacteria, 
bacterial products, and dietary antigens, which all   necessitate 
the need for correct and efficient immune responses for 
homeostasis to be maintained.34–36 This is achieved through 
the GALT, with the mucosa of the GIT itself possessing the 
largest and most complex portion of the body’s immune 
system, with about 75% of all the body’s immune cells 
being localized to the GIT.35–37 The small intestine’s GALT 
possesses lymphoid elements in the form of Peyer’s Patches, 
mesenteric lymph nodes (MLN), and isolated lymphoid fol-
licles.18,35,38 These lymphoid elements are composed of T and 
B lymphocytes; with the intestinal T cell populations being 
important participants in the mucosal barrier through their 
sensing of invading bacteria and their secreting of cytok-
ines for the regulation of other infiltrating immune cells.18 
The effecter cells, regulated by the intestinal lymphocytes, 
are situated in the mucosa too and comprise lymphocytes, 
dendritic cells, macrophages, neutrophils, granulocytes, 
and mast cells.18,34
Intestinal macrophages constitute about 10%–20% of 
all the mononuclear cells in the intestinal lamina propria 
as well as being the largest collection of macrophages 
in the body.36 They are continually recruited from blood 
monocytes and show a larger population size within the 
small intestine in comparison to the large intestine.35,36 Tis-
sue macrophages are known to be essential in maintaining 
homeostasis by participating in the removal of altered cells, 
tissue remodeling, repair, and inflammation. The intestinal 
macrophages, though, are unlike other tissue macrophages, 
showing only minimal inflammation capabilities and are 
incapable of acting as professional antigen presenting cells.36 
It is believed that this nature of intestinal macrophages is 
the result of their co-evolution with their host’s intestinal 
flora so as to diminish continual stimulation of inflamma-
tion and thus maintain local tissue homeostasis. They have 
low, or even absent, expression of surface CD48, CD8, and 
CD86; low levels of proinflammatory cytokine production 
and are relatively unreceptive to proinflammatory stimuli, 
for example they do not respond to lipopolysaccharide.35,36 
They do, however, still act as powerful phagocytic cells, 
showing potent   bactericidal activates.36
Under control conditions most of the body’s eosinophils 
are recruited into the GIT’s lamina propria, excluding the 
esophagus. Their levels occur independently of lymphocyte 
and enteric flora levels, indicating a unique regulation sys-
tem for their recruitment in comparison to other leukocytes. 
This regulation is achieved by the continual expression of 
eoxatin-1 by the GIT, which recruits this leukocyte.19
During asthma the bronchial epithelium and lamina 
propria show infiltration of lymphocytes and eosinophils, 
and this feature has also been found in the small intestine of 
asthmatics. Additionally, the intestinal lamina propria has 
shown increased mast cell infiltration.5,7 This infiltration of 
lymphocytes and mononuclear cells into the lamina propria 
does not differ between allergic and non-allergic asthmatics 
although treatment has been seen to induce an effect. Those 
utilizing oral steroids, when suffering from severe asthma, 
show significantly lower mast cell and lymphocyte counts 
than those who utilize inhaled steroids, when suffering from 
moderate asthma, and those who remain untreated, due to 
suffering from only mild asthma.5 These features would 
appear to indicate that the small intestine of asthmatics is 
likely to be in a state of inflammation.20,25
Mucosal lesions are seen in GSE, which are mediated 
by the action of T cells. As bronchial asthma is considered 
to be a T cell-mediated disease, it has been hypothesized 
that the lesions present in the small intestine of asthmatics 
are facilitated by a similar mechanism to that occurring 
in GSE.5
GiT permeability
Benard et al (1996) revealed, through the utilization of the 
Chromium ethyleneddiaminetetraacetic acid (CrEDTA) 
test, that the small intestine of asthmatics showed increased 
permeability in comparison to that of control patients. The 
permeability did not differ between allergic and non allergic 
asthmatics, severity of the disease, or the steroid treatments 
utilized.6 The CrEDTA test is a highly sensitive but low 
specificity test. This test unfortunately did not reveal the 
location of the small intestine’s permeability, although the 
involvement of the small intestine’s tight junctions has been 
proposed.6 The mechanism for this increased permeability 
in asthmatics is unknown; it is unlikely that this feature is a 
result of the common mucosal system as it has not be found 
to correlate with factors of airway asthma, such as disease 
severity and treatment utilization.6Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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Goblet cell alterations
Amongst the resident epithelium cells population of the small 
intestines mucosa, there exists a group of specialized cells 
known as goblet cells. These cells, although at much lower con-
centrations than their simple columnar counter parts, provide 
each villi of the small intestine with a peppered appearance.2,8,9 
These cells are responsible for the small intestine’s mucus pro-
duction, which protects and lubricates the luminal walls.1,9
A characteristic of allergic inflammation seen in the small 
intestine in Ozdemir et al’s 2007 study was that ovalbumin 
(OVA) sensitized mice showed increased mucus production, 
facilitated by the mucosa’s goblets cells. The goblets cells 
were noted to increase both in number and size. The mean 
goblet size in the duodenum was found to roughly double, 
while that in the jejunum and ileum increased roughly 
3-fold.39 Goblet cell hyperplasia and increased mucus 
production is commonly described within the airways of 
asthmatics.26 The presence of goblet cell hyperplasia in mild 
and moderate asthmatics has been attributed with roughly a 
3-fold increase in goblet cell number and stored mucus vol-
ume in comparison to controls and hence is comparable to 
that seen in the small intestines of the sensitized mice studied 
by Ozdemir et al.27,39,40 Unfortunately, although comparable, 
a clear relationship between intestinal goblet cell hyperplasia 
and hyperfunctioning could not be extrapolated as Ozdemir 
and coworkers only considered the one-way effect of a 
food allergen presented intragastricularly that subsequently 
induced asthma. Whether the process works in the reverse, 
so that asthma alone induces the same responses in the small 
intestines goblets cells, was not examined.39
Villous atrophy
The entire small intestine possesses permanent parallel 
folds, referred to as plica circularis, which are formed by 
the mucosa and part of the submucosa. Upon each of these 
folds lie extensions known as villi, constituted by the lamina 
propria and epithelium of the mucosa.1,2,8,9 Upon the mucosa 
of these extensions lie a large population of simple columnar 
epithelium cells in the possession of microvilli upon their 
luminal surfaces.1,2,8,9 The plica circularis, villi, and microvilli 
all contribute to a larger surface area through which nutrient, 
water, and electrolyte absorption can take place.1,2,8,9
In an experimental study with mice given OVA intra-
gastrically and intraperitoneally a significant decrease was 
found in their villous/crypt ratio – villous atrophy – due to 
a reduction in villi height as well as an increase in crypt 
depth.39,41 Mice sensitized with OVA only intraperitoneally 
showed an increase in their villous/crypt ratio, although 
this process was also suggested to be a proinflammatory 
response of the mucosa to the antigen.39 The mice sensitized 
by OVA both intragastrically and intraperitoneally, with a 
predisposition to the antigen, developed allergic airway 
responses as well. The antigen therefore appears to be 
taken up by the GIT and presented preferentially to naïve 
T lymphocytes in the Peyer’s Patches of the small intestine. 
The T cells would then be primed and subsequently enter 
the blood stream to travel to other immune mucosal sites, 
such as that of the respiratory system, or they would remain 
in the GIT.39 However, whether the induction of asthma 
subsequently facilitate villous atrophy was not assessed. 
One cannot assume from these results that the induction of 
asthma first would induce villous atrophy, as the process of 
villous atrophy may only be a unidirectional event requir-
ing solely gastrointestinal antigen exposure rather than the 
induction of asthma. Although partial villous atrophy is seen 
amongst human asthmatics as well as surface, pit, crypt, and 
glandular epithelium atrophy in the duodenum, it was not 
stated or even considered if their asthma arose from gastro-
intestinal antigen exposure(s), as was the case for the mice 
studied by Ozdemir and coworkers, which creates suspicion 
as to whether or not the perceived atrophy was a result of 
intragastricular food allergen exposure.5,7
Clinical relevance
The full clinical relevance of asthma’s GIT impact has not 
been examined within the literature to date. The most likely 
consequence for asthmatic patients would be impaired diges-
tive and absorption functions as well increased risk of disease 
contraction. The cellular atrophy noted within the GIT would 
be a likely means for reduced nutrient digestion and absorp-
tion. The undigested and unabsorbed nutrients and electrolytes 
in the intestines could further more osmotically withdraw 
fluids from of the intestines inducing diarrhea.42–45 A further 
implication of cellular atrophy would be the formation of GIT 
ulcerations. Increased mucosal permeability described by 
Benard and coworkers in 1996 would entail increased bacterial 
and bacterial product uptake. This would subsequently trigger 
further immune activation and inflammation within the GIT 
and possibly induce various related diseases.6,44–48
Conclusion
It can be concluded from the above review of literature, that 
studies conducted so far appear to support the hypothesis Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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that a link exists between bronchial asthma and the GIT, 
particularly when considering features such as increased 
leukocyte infiltration, goblet cell alterations, fibrosis, and 
cytokine alterations, which are characteristic of asthmatic 
airways and lung tissues. Unfortunately, our understanding of 
this asthma-GIT relationship is still limited. Further research 
is required in order to completely validate the suggested 
hypothesis and make sure that the perceived results are not 
the result of ingested food allergens, as may have been the 
case in the study by Ozdemir and coworkers.
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